These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27454106)

  • 1. Methylated arginine analogues: their potential role in atherosclerosis and cognition using the poloxamer-407-induced mouse model of dyslipidemia.
    Gilinsky MA; Johnston TP; Zhukova NA; Dubrovina NI; Latysheva TV; Naumenko SE; Sukhovershin RA
    Can J Physiol Pharmacol; 2016 Nov; 94(11):1122-1131. PubMed ID: 27454106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylarginines in Mice with Experimental Atherosclerosis.
    Gilinsky MA; Sukhovershin RA; Cherkanova MS
    Bull Exp Biol Med; 2015 Nov; 160(1):13-6. PubMed ID: 26601840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C and chitotriosidase in acute P-407 induced dyslipidemia: Can they serve as potential early biomarkers for atherosclerosis?
    Korolenko TA; Pisareva EE; Filyushina EE; Johnston TP; Machova E
    Exp Toxicol Pathol; 2015 Sep; 67(9):459-66. PubMed ID: 26129870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of acute renal injury on arginine and methylarginines metabolism.
    Sukhovershin RA; Gilinsky MA
    Ren Fail; 2013; 35(10):1404-11. PubMed ID: 23991715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition.
    Servillo L; Giovane A; Cautela D; Castaldo D; Balestrieri ML
    Nitric Oxide; 2013 Apr; 30():43-8. PubMed ID: 23438481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of regulation of endogenous methylarginine concentrations in clinical practice].
    Kopieczna-Grzebieniak E; Goss M
    Przegl Lek; 2005; 62(12):1494-501. PubMed ID: 16786781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages.
    Johnston TP; Li Y; Jamal AS; Stechschulte DJ; Dileepan KN
    Mediators Inflamm; 2003 Jun; 12(3):147-55. PubMed ID: 12857598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 mice.
    Johnston TP
    J Pharm Pharmacol; 2010 Dec; 62(12):1807-12. PubMed ID: 21054409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia.
    Ercan M; Firtina S; Konukoglu D
    Clin Hemorheol Microcirc; 2014; 57(4):315-23. PubMed ID: 23455843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain inhibitor I attenuates atherosclerosis and inflammation in atherosclerotic rats through eNOS/NO/NF-κB pathway.
    Yu L; Yin M; Yang X; Lu M; Tang F; Wang H
    Can J Physiol Pharmacol; 2018 Jan; 96(1):60-67. PubMed ID: 28758430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of citrulline, arginine, and methylarginines using high-performance liquid chromatography.
    Wu G; Meininger CJ
    Methods Enzymol; 2008; 440():177-89. PubMed ID: 18423217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of free methylarginines via the proteasome and autophagy pathways in cultured cells.
    Shirakawa T; Kako K; Shimada T; Nagashima Y; Nakamura A; Ishida J; Fukamizu A
    Mol Med Rep; 2011; 4(4):615-20. PubMed ID: 21584492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage atherosclerosis in poloxamer 407-induced hyperlipidemic mice: pathological features and changes in the lipid composition of serum lipoprotein fractions and subfractions.
    Korolenko TA; Johnston TP; Tuzikov FV; Tuzikova NA; Pupyshev AB; Spiridonov VK; Goncharova NV; Maiborodin IV; Zhukova NA
    Lipids Health Dis; 2016 Jan; 15():16. PubMed ID: 26801626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery.
    Xuan C; Chang FJ; Liu XC; Bai XY; Liao XL; He GW; Ou JS
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):697-703. PubMed ID: 22336756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.